Gregory Schwartz, MD, Cardiology, Denver, CO, Veterans Affairs Eastern Colorado Health Care System

GregoryGlennSchwartzMD

Cardiology Denver, CO

Adult Congenital Heart Disease

Professor, Medicine, University of Colorado School of Medicine

Are you Dr. Schwartz?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 59 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    1055 Clermont St
    Cardiology 111b, Denver Va Medical Center
    Denver, CO 80220
    Phone(303) 393-2826
    Fax(303) 393-5054
  • Is this information wrong?

Summary

  • Dr. Gregory Schwartz, MD is a cardiologist in Denver, Colorado. He is currently licensed to practice medicine in Colorado, California, and Texas. He is affiliated with Veterans Affairs Eastern Colorado Health Care System and is a Professor at University of Colorado School of Medicine.

Education & Training

  • University of Colorado
    University of ColoradoResidency, Internal Medicine, 1982 - 1985
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1982

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1999 - 2021
  • CA State Medical License
    CA State Medical License 1986 - 2022
  • TX State Medical License
    TX State Medical License Active through 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • Sanofi: ODYSSEY OUTCOMES Investigators Highlight at AHA That Praluent® (Alirocumab) Was Associated with Fewer Deaths from Any Cause
    Sanofi: ODYSSEY OUTCOMES Investigators Highlight at AHA That Praluent® (Alirocumab) Was Associated with Fewer Deaths from Any CauseNovember 11, 2018 16:39
  • ODYSSEY OUTCOMES Investigators Highlight at AHA That Praluent (Alirocumab) Injection Was Associated with Fewer Deaths from Any Cause
    ODYSSEY OUTCOMES Investigators Highlight at AHA That Praluent (Alirocumab) Injection Was Associated with Fewer Deaths from Any CauseNovember 11, 2018 16:39
  • Among Heart Attack Survivors, Drug Reduces Chances of Second Heart Attack or Stroke
    Among Heart Attack Survivors, Drug Reduces Chances of Second Heart Attack or StrokeNovember 10, 2018 17:17
  • Join now to see all

Professional Memberships

Hospital Affiliations